Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here:

Press releases

February 12, 2018

Invitation to presentation of Immunovia´s Full Year Report 2017 on February 15, 2018

Read press release
February 8, 2018

Massachusetts General Hospital joins PanFAM-1 prospective study for the early detection of pancreatic cancer in familiar risk groups

Read press release
January 11, 2018

Immunovia accelerates pancreas cancer study of new onset diabetics by adding Denmark’s Diabetes Center for Strategic Research-DD2

Read press release
December 22, 2017 | REGULATORY

Immunovia expands multicenter clinical study for early detection of pancreatic cancer through collaboration with the renowned University of Pittsburgh

Read press release
December 20, 2017 | REGULATORY

Sahlgrenska University Hospital first Swedish site in the largest ever prospective clinical study for early detection of pancreatic cancer

Read press release
December 18, 2017

Invitation to Immunovia’s telephone conference on Wednesday, the 20th of December, 2017 at 15:00 (CET)

Read press release
December 18, 2017 | REGULATORY

Immunovia initiates the world’s largest study of new onset diabetic patients in a prospective pancreas cancer study supported by SWElife

Read press release
November 30, 2017

The Swedish Royal Technology Mission 2017 and His Majesty King Carl XVI Gustaf of Sweden visited Immunovia yesterday

Read press release
November 16, 2017

World Pancreatic Cancer Day is today: If pancreatic cancer is found early, it saves lives

Read press release
November 13, 2017

Immunovia will hold a Q3 report telephone conference on Monday Nov 13th

Read press release
November 10, 2017 | REGULATORY

Immunovia Interim report, January-September 2017

Read press release
November 7, 2017 | REGULATORY

Immunovia AB (Publ) nomination committee appointed for AGM 2018

Read press release
1 19 20 21 22 23 27